A phase 2 study of TXA127 for the treatment of stroke recovery.
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Angiotensin-1-7 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 02 Apr 2018 New trial record
- 27 Mar 2018 According to a Constant Pharmaceuticals media release, company plans to initiate this trial in early 2019.